Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

575
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
575
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

62
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
62
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

75
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
75
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

222
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
222
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

28
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
28

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A single-cell atlas of ulcerative colitis reveals neutrophil-stromal circuits linked to biologic therapy resistance.

Frontiers in immunology·2026
Same author

Integrating Patient Engagement into Clinical Pharmacology and Pharmacometrics: Bringing the Patient Voice into Data-Driven Science.

Clinical pharmacology and therapeutics·2026
Same author

Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development.

Clinical pharmacology and therapeutics·2025
Same author

A Generalized Minimal PBPK-PD Model of Bispecific Antibodies: Case Studies and Applications in Drug Development.

CPT: pharmacometrics & systems pharmacology·2025
Same author

A quantitative systems pharmacology model to inform clinical translation of dynamic PKPD relationships of engineered IL-15.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025
Same author

Leveraging quantitative systems pharmacology modeling for elranatamab regimen optimization in relapsed or refractory multiple myeloma.

NPJ systems biology and applications·2025

Related Experiment Video

Updated: Jun 2, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.5K

Future Directions for Quantitative Systems Pharmacology.

Birgit Schoeberl1, Cynthia J Musante2, Saroja Ramanujan3

  • 1Biomedical Research, Novartis, Cambridge, MA, USA.

Handbook of Experimental Pharmacology
|January 15, 2025
PubMed
Summary
This summary is machine-generated.

Quantitative Systems Pharmacology (QSP) will integrate advanced analytics, machine learning (ML), and artificial intelligence (AI) for drug discovery. This evolution will enhance model building, data integration, and precision medicine applications throughout development.

Keywords:
Clinical trial simulationDigital twinsMachine learning and artificial intelligenceMicrophysiological systemsModeling and simulationQuantitative systems pharmacologyVirtual patients

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
00:05

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

13.8K

Related Experiment Videos

Last Updated: Jun 2, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.5K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
00:05

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

13.8K

Area of Science:

  • Pharmacology
  • Computational Biology
  • Drug Development

Background:

  • Quantitative Systems Pharmacology (QSP) is evolving with new data and technologies.
  • Advanced analytics, machine learning (ML), and artificial intelligence (AI) are key drivers of this evolution.
  • Integrating diverse and large datasets is crucial for QSP advancements.

Purpose of the Study:

  • To envision the future integration of QSP with emerging technologies and data.
  • To outline the role of QSP across all stages of drug discovery and development.
  • To identify key strategies for QSP evolution and its impact on precision medicine.

Main Methods:

  • Integration of ML/AI for data handling and model simulation in QSP.
  • Application of QSP in drug discovery, predicting in silico compound performance.
  • Utilizing QSP with non-animal methodologies and patient data for preclinical and clinical development.
  • Developing multidimensional digital twins and virtual populations for clinical trial simulations.

Main Results:

  • QSP models will predict early human responses to novel compounds.
  • QSP will enhance understanding and translation from preclinical to human patients.
  • Multidimensional digital twins and virtual populations will guide clinical trials and precision medicine.
  • QSP expert roles will expand to strategy, data evaluation, analysis execution, and ethical application of new technologies.

Conclusions:

  • QSP's future lies in integrating advanced data, analytics, and technologies like AI/ML.
  • This integration will enable QSP applications across the entire drug discovery and development pipeline.
  • Strategic evolution through high-impact applications, analytical integration, and efficiency gains is essential for QSP's future role in precision medicine.